From 2013 to 2023, the output of basic pharmaceutical products and pharmaceutical preparations in Belgium exhibited substantial growth. The value stood at 34.06 Billion Euros in 2023, marking an impressive CAGR of 11.7% over the last five years. While year-on-year variations fluctuated, notable peaks include 18.35% in 2016 and 20.83% in 2019. However, certain years such as 2017 saw minimal growth of 0.5%, and slower growth in 2021 at 6.21%. Overall, the sector displayed robust expansion with a series of upward trends.
Forecasts indicate continued positive momentum with a forecasted CAGR of 4.96% from 2024 to 2028, translating to a 27.39% growth rate over this period. Future trends to watch for include:
- Potential market saturation and shifts in the competitive landscape.
- Impact of regulatory changes and healthcare policies.
- Investment in innovative pharmaceutical technologies.
- Global economic factors influencing supply chains and demand.
- Ongoing effects of strict environmental regulations and sustainability initiatives.
